Pneumococcal infection in children: Rational antibiotic choice for drug-resistant Streptococcus pneumoniae

Acta Paediatrica Taiwanica

Volumn 44, Issue 2, 2003, Pages 67-74

  Chiou, Christine C ^a,b   Hseih, Kai Sheng ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b Department of Nursing   (Taiwan)

Author keywords

Rsistance; Streptococcus pneumoniae

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CLARITHROMYCIN; CLINDAMYCIN; DEXAMETHASONE; ERYTHROMYCIN; LINEZOLID; MACROLIDE; MEROPENEM; NETILMICIN; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLONE DERIVATIVE; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL MENINGITIS; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; DRUG MEGADOSE; ENZYME SYNTHESIS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; PREVALENCE; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TAIWAN;

ADULT; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; INFANT; MENINGITIS, PNEUMOCOCCAL; OTITIS MEDIA; PENICILLIN RESISTANCE; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; STREPTOCOCCUS PNEUMONIAE; TAIWAN;

EID: 0037709885     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 1996; 15:932-4.
2. Klein JO. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis 1981; 3:246-53.
3. Ghaffar F, Friedland IR, McCracken GH Jr. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J 1999; 18:638-46.
4. Gray BM, Converse GM 3rd, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980; 142:923-33.
5. Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000; 30:122-40.
6. Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 2000; 30:100-21.
7. Chiang CJ, Hwang KP, Peng CF, Kuo CS. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae infections in Kaohsiung from 1996 through 1999. J Microbiol Immunol Infect 2001; 34:269-74.
8. Chiou CC, Liu YC, Huang TS, et al. Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan. J Clin Microbiol 1998; 36:1933-7.
9. Siu LK, Chu ML, Ho M, Lee YS, Wang CC. Epidemiology of invasive pneumococcal infection in Taiwan: antibiotic resistance, serogroup distribution, and ribotypes analyses. Microb Drug Resist 2002; 8:201-8.
10. Andersson B, Eriksson B, Falsen E, et al. Adhesion of Streptococcus pneumoniae to human pharyngeal epithelial cells in vitro: differences in adhesive capacity among strains isolated from subjects with otitis media, septicemia, or meningitis or from healthy carriers. Infect Immunol 1981; 32:311-7.
11. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, ed. 2000 red book: report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2000; 457.
12. Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR-Morbidity & Mortality Weekly Report 2000; 49:1-35.
13. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967; 2:264-5.
14. Andes D. Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections. Curr Opin Infect Dis 2001; 14:165-72.
15. Hansman D, Glasgow H, Sturt J, Devitt HL, Douglass R. Increased resistance to pencillin of pneumococci isolated from man. N Engl J Med 1971; 284:175-7.
16. Appelbaum PC, Bhamjee A, Scragg JN, Hallett AF, Bowen AJ, Cooper RC. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977; 2:995-7.
17. Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978; 299:735-40.
18. National Committee for Clinical Laboratory Standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard M100-S10. National Committee for Clinical Laboratory Standard, Wayne, PA, 2000.
19. Chang SC, Hsieh WC, Liu CY. High prevalence of antibiotic resistance of common pathogenic bacteria in Taiwan. The Antibiotic Resistance Study Group of the Infectious Disease Society of the Republic of China. Diagn Microbiol Infect Dis 2000; 36:107-12.
20. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39:1988-92.
21. Deeks SL, Palacio R, Ruvinsky R, et al. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics 1999; 103:40913.
22. Malley R, Ambrosino D. Pneumococcal diseases in children: morbidity, mortality, and resistance. University of Chicago Children's Hospital Reports on Current Concepts in the Use of Pediatric Vaccines 1998; 1:1-8.
23. Kaplan SL, Mason EO Jr. Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Rev 1998; 11:628-44.
24. Pelton SI. Defining resistance: breakpoints and beyond implications for pediatric respiratory infection. Diagn Microbiol Infect Dis 1996; 25:195-9.
25. Craig WA, Andes DR. Pharmacokinetcs and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 15:255-9.
26. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26:1-12.
27. Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infectious. J Chemother 1997; 9(Suppl): 38-44.
28. Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics 1999; 103(Suppl E):28.
29. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337:970-6.
30. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 1993; 12:389-94.
31. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med 1993; 22:1198-210.
32. Arditi M, Mason EO Jr., Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102:1087-97.
33. Pikis A, Kavaliotis J, Tsikoulas J, Andrianopoulos P, Venzon D, Manios S. Long-term sequelae of pneumococcal meningitis in children. Clin Pediatr 1996; 35:72-8.
34. Friedland IR, Paris M, Ehrett S, et al. Evaluation of antimicrobial regimens for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993; 37:1630-6.
35. Kaplan SL, Mason EO Jr., Barson WJ, et al. Three-year multicenter surveillance of systemic pneumococcal infections in children. Pediatrics 1998; 102:538-45.
36. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998; 152:624-8.
37. McCullers JA, English BK, Novak R. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis 2000; 181:369-73.
38. Jacobs NM, Lerdkachornsuk S, Metzger WI. Pneumococcal bacteremia in infants and children: a ten-year experience at the Cook County Hospital with special reference to the pneumococcal serotypes isolated. Pediatrics 1979; 64:296-300.
39. Metlay JP, Hofmann J, Cetron MS, et al. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia. Clin Infect Dis 2000; 30:520-8.
40. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J 1995; 14: 885-90.
41. Choi EH, Lee HJ. Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children. Clin Infect Dis 1998; 26:1346-54.
42. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999; 18:1-9.
43. Dowell SF, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician 1997; 55:1647-54, 1657-8.
44. Nelson CT, Mason EO Jr., Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994; 13:585-9.
45. Wald ER. Sinusitis in children. N Engl J Med 1992; 326: 319-23.